Hitoshi Funabashi
Impact in
-
- Effects and risks of endocrine disrupting chemicals
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Metabolomics and Mass Spectrometry Studies 3
- Pluripotent Stem Cells Research 3
- Oncology 5
- Drug Transport and Resistance Mechanisms 4
- Co-authors
- Takeshi Kunimatsu (10 shared papers)Juki Kimura (12 shared papers)Takaki Seki (9 shared papers)Izuru Miyawaki (9 shared papers)Kiyoko Bando (3 shared papers)Takeshi Bamba (2 shared papers)Eiichiro Fukusaki (2 shared papers)Jun Sakai (2 shared papers)
- Journals
- Toxicology and Applied Pharmacology (3 papers)Regulatory Toxicology and Pharmacology (3 papers)Mutation Research/Genetic Toxicology and Environmental Mutagenesis (2 papers)Experimental and Toxicologic Pathology (1 paper)Toxicologic Pathology (1 paper)
- Partner nations
- JapanUnited States
In The Last Decade
Hitoshi Funabashi
27 papers receiving 577 citations
Peers
Comparison fields: 5 of 96
- Health, Toxicology and Mutagenesis 84
- Pharmacology 49
- Molecular Biology 279
- Small Animals 22
- Spectroscopy 49
Countries citing papers authored by Hitoshi Funabashi
This map shows the geographic impact of Hitoshi Funabashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Funabashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Funabashi more than expected).
Fields of papers citing papers by Hitoshi Funabashi
This network shows the impact of papers produced by Hitoshi Funabashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Funabashi. The network helps show where Hitoshi Funabashi may publish in the future.
Co-authors
The 25 scholars most cited alongside Hitoshi Funabashi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor beta chain and p53 double-knockout mice. | 2001 | 123 |
| 2 | 2010 | 86 | |
| 3 | 2012 | 55 | |
| 4 | 2010 | 47 | |
| 5 | 2014 | 44 | |
| 6 | 2014 | 35 | |
| 7 | 2003 | 28 | |
| 8 | 2010 | 24 | |
| 9 | 2010 | 24 | |
| 10 | 2014 | 22 | |
| 11 | 2015 | 15 | |
| 12 | 2000 | 14 | |
| 13 | 2015 | 11 | |
| 14 | 2015 | 9 | |
| 15 | 2015 | 8 | |
| 16 | 2012 | 7 | |
| 17 | 2015 | 6 | |
| 18 | 2012 | 5 | |
| 19 | 2013 | 4 | |
| 20 | 2011 | 4 |
About Hitoshi Funabashi
Hitoshi Funabashi is a scholar working on Molecular Biology, Oncology, Cellular and Molecular Neuroscience, Pharmacology and Endocrinology, Diabetes and Metabolism, having authored 28 papers that have together received 588 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (4 papers), Carcinogens and Genotoxicity Assessment (3 papers), Neuroscience and Neural Engineering (3 papers), Effects and risks of endocrine disrupting chemicals (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Metabolomics and Mass Spectrometry Studies (3 papers), Pluripotent Stem Cells Research (3 papers) and Cardiac electrophysiology and arrhythmias (2 papers). The work is most often cited by research in Health, Toxicology and Mutagenesis (84 citations), Pharmacology (49 citations), Molecular Biology (279 citations), Small Animals (22 citations) and Spectroscopy (49 citations). Hitoshi Funabashi has collaborated with scholars based in Japan and United States. Frequent co-authors include Takeshi Kunimatsu, Juki Kimura, Takaki Seki, Izuru Miyawaki, Kiyoko Bando, Takeshi Bamba, Eiichiro Fukusaki, Jun Sakai, Hiroshi Inada and Yuriko Nagata. Their work appears in journals such as Toxicology and Applied Pharmacology, Regulatory Toxicology and Pharmacology, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Experimental and Toxicologic Pathology and Toxicologic Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.